IHS Chemical Week

Chemical Week Magazine :: Newsbriefs

Russian pharma firm buys API supplier for $590 million

6:19 AM MDT | September 6, 2013

Pharmstandard (Moscow), Russia’s leading pharmaceutical company, says it will acquire Bever Pharmaceutical (Singapore), a supplier of active pharmaceutical ingredients (APIs), for $590 million. Russian businessman Alexander Shuster, a nonexecutive board member of Pharmstandard, currently owns 100% of Bever. Pharmstandard says it is buying Bever to secure a long-term supply of critical APIs for two flagship OTC brands of Pharmstandard—Arbidol and Aphobazolum—at lower cost, increase the profitability of the OTC business, improve flexibility, and manage APIs...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa